WKYT: “Lexington cancer doctor saving women’s lives”

Cesium-131 Brachytherapy pioneer, Dr. Jonathan Feddock was recently featured by WKYT, leading the fight against recurrent gynecologic cancer. “It's estimated every six minutes in this country, a doctor diagnoses a woman with gynecologic cancer or cancer of the...
Read More

IsoRay CEO Thomas LaVoy Talks The Future Of Cesium-131 Brachytherapy With The Wall Street Transcript

The Wall Street Transcipt recently sat with IsoRay CEO Thomas LaVoy to gain insights into the company's isotope used in brachytherapy, the patient experience, and the future of Cesium-131 in additional markets. IsoRay, Inc. (NYSEMKT: ISR) THOMAS LAVOY is Chairman of...
Read More

New guidelines and targeted treatment: insights from AUA 2017

Amidst a trove of news surrounding prostate cancer treatment, the 2017 edition of the American Urological Association annual conference convened earlier this month in Boston. The meeting hosted approximately 10,000 attendees and maintained its focus on prostate cancer...
Read More

Prostate Cancer News Today: “Prostate Cancer Patients Treated with Radioactive Seeds Retain Urinary, Bowel Quality”

“Prostate cancer patients treated with Cesium-131 brachytherapy maintained their urinary- and bowel-related quality of life years afterward, according to a recent study.” The study, “Long-term Quality of Life in Prostate Cancer Patients Treated with Cesium-131,” was...
Read More

ABS 2017 Insights and Takeaways

A thorough discussion on value, detailed brachytherapy delivery techniques and ways clinicians can reach new patients: Isoray’s ABS 2017 insights and takeaways including Dr. Steven Frank, Dr. Alex Hsi and Harvard Business School Professor Emeritus Dr. Robert Kaplan.

Read More

Recent News

WKYT: “Lexington cancer doctor saving women’s lives”

Cesium-131 Brachytherapy pioneer, Dr. Jonathan Feddock was recently featured by WKYT, leading the fight against recurrent gynecologic cancer. “It's estimated every six minutes in this country, a doctor diagnoses a woman with gynecologic cancer or cancer of the...

New guidelines and targeted treatment: insights from AUA 2017

Amidst a trove of news surrounding prostate cancer treatment, the 2017 edition of the American Urological Association annual conference convened earlier this month in Boston. The meeting hosted approximately 10,000 attendees and maintained its focus on prostate cancer...

Cs-131 is a favorable isotope for use across a wide range of tumors and its dose distribution properties facilitate easy calculation and use in the clinic. Dr. Voichita Bar-Ad

Thomas Jefferson University Hospital

Find A Cesium Pioneer Near You

Doctors going above and beyond against the fight with cancer. Learn More

All News

WKYT: “Lexington cancer doctor saving women’s lives”

Cesium-131 Brachytherapy pioneer, Dr. Jonathan Feddock was recently featured by WKYT, leading the fight against recurrent gynecologic cancer. “It's estimated every six minutes in this country, a doctor diagnoses a woman with gynecologic cancer or cancer of the...

IsoRay Announces Study Accepted for Publication in The International Journal of Radiation Oncology, Biology, Physics entitled “Long-term Quality of Life in Prostate Cancer Patients Treated with Cesium-131”

At Median 5.5 Years Post-Treatment, Return to Baseline is Sustained RICHLAND, Wash., May 3, 2017 /PRNewswire/ -- IsoRay, Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of...

ABS 2017 Insights and Takeaways

A thorough discussion on value, detailed brachytherapy delivery techniques and ways clinicians can reach new patients: Isoray’s ABS 2017 insights and takeaways including Dr. Steven Frank, Dr. Alex Hsi and Harvard Business School Professor Emeritus Dr. Robert Kaplan.

Isoray Patients Tell Their Stories

Herbert L   During Herbert’s initial diagnosis for localized prostate cancer, his physician advised that he see a urologist. After having tests run at the Chicago Prostate Cancer Center with Dr. Brian Moran, Herbert learned about his options for treatment, one of...

Bringing Compassion and Hope to Cancer Patients

The following article originally appeared in the Winter/Spring 2017 MicroCap Review Magazine. A small company in Richland, WA is dedicated to making a difference in the lives of patients diagnosed with different forms of cancer. Isoray Medical, Inc. [NYSE MKT:ISR] has...